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1. The intestinal transport of glycine and leucine residues of glycyl-L-leucine was
studied in the monkey and in the human in vitro. Uptake of both [14C]glycyl-L-leucine
and glyCyl-L-(14C]leucine show similar K, values, but there is a marked difference in the
V.... values. Preliminary studies suggest that this anomalous difference in the V...
values may be due to the greater efflux rate of glycine from the tissue. 2. Arrhenius plots
of both (14C]glycyl-L-leucine uptake and glycyl-L-[14C]leucine uptake in the monkey
intestine show a discontinuity at about 20°C. The activation energies above and below the
discontinuity are similar for both [14C]glycyl-L-leucine uptake and glycyl-L-[14C]leucine
uptake. These similarities in uptake characteristics suggest that the dipeptide glycyl-L-
leucine is transported as one unit. 3. In the monkey intestine, glycyl-L-leucine uptake is
inhibited by a wide variety of dipeptides, including those containing acidic and basic
amino acids. The inhibition was shown to be competitive by using four representative
dipeptides namely: L-alanyl-L-alanine, L-alanyl-L-leucine, L-glutamyl-L-glutamic acid
and L-lysyl-L-lysine. The results strongly suggest that in the monkey intestine there
may be a dipeptide-uptake system with an extremely broad specificity. These results
were also confirmed in the human in a limited way.
Long neglected since the original observation of
Newey& Smyth (1959), the role ofpeptide absorption
in the terminal stages ofprotein digestion in the small
intestine is now being increasingly recognized. In
recent years intestinal dipeptide absorption has
been studied in various mammalian species, including
the human (Lis et al., 1971; Adibi, 1971; Hellier et
al., 1972a; for a review, see Matthews, 1972). A
peptide-transport system distinct from the amino
acid-transport systems has been shown to be present
in most animal species, but the actual mechanism
of uptake is still largely unknown. A preliminary
study (Das & Radhakrishnan, 1974b) on glycyl-L-
leucine uptake in monkey intestine showed that
the specificity of the uptake system was similar to
the substrate specificity of the monkey intestinal
glycyl-L-leucine hydrolase (Das & Radhakrishnan,
1972, 1973) in its broad scope, but was different in
some crucial respects. This indicated that the initial
entry process for dipeptides may be independent
of the action of the 'master' dipeptidase. Although
the dipeptidases may not be directly involved in the
uptake process, an indirect role was suggested by the
observation that the VmaxlKt value for uptake was
the highest in the jejunal region, which was shown
earlier to be the site of maximal activity of the
glycyl-L-leucine hydrolase (Das & Radhakrishnan,
1974a). The studies ofDas & Radhakrishnan (1974b)
in monkey intestine also showed that the properties
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of the glycyl-L-leucine-uptake system are quite differ-
ent from that of free amino acid uptake. Later, when
radioactive glycyl-L-leucine, labelled in either the
glycine or the leucine residue, became available, a
more detailed study of the characteristics of the
uptake process was made both in the monkey and in
the human. The results of these studies are reported
in the present paper.
Experimental
Chemicals
(14C]Glycyl-L-leucine and glycyl-L-['4C]leucine
were from The Radiochemical Centre, Amersham,
Bucks., U.K. The unlabelled peptides were obtained
as indicated. L-Glutaminyl-L-glutamine was kindly
donated by Professor Alton Meister (Cornell
University, New York, N.Y., U.S.A.). L-Glutamyl-
L-glutamic acid, L-tyrosyl-L-lysine, and glycyl-L-
leucyl-L-glycine were from Schwarz/Mann, Orange-
burg, N.Y., U.S.A. All other peptides were from
Sigma Chemical Co., St. Louis, Mo., U.S.A. The
peptides were all chromatographically pure.
All other chemicals were ofanalytical grade.
Uptake experiments
Adult male monkeys (Macaca radiata) in the weight
range 4-6kg were used. The region of intestine at
35-40% distance of the total length of intestine from
the pyloric end was used in all these experiments.
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An earlier study (Das & Radhakrishnan, 1974b)
had shown this region to be the most active site for
peptide uptake. Small rectangular strips of intestine
were used in all the uptake experiments.
The surgical specimen of the human intestine
(7.6cm long) was resected from the jejunal region of
a patient undergoing corrective surgery for compli-
cations arising after a gastroenterostomy. It was
immediately transferred into ice-cold oxygenated
Krebs-Ringer bicarbonate buffer (Umbreit et al.,
1964) containing 0.5% glucose. Pieces of the mucosal
layer were carefully removed and small bits
weighing between 15 and 20mg were used for the
uptake studies, the procedure for which was the same
as for the monkey intestinal strips.
Uptake experiments were carried out under the
same conditions as described previously (Das &
Radhakrishnan, 1974b), except for a few modifi-
cations. Each intestinal strip (10-20mg) was pre-
incubated at the same temperature as the incubation
step, with shaking for 5min in 2ml of oxygenated
Krebs-Ringer bicarbonate buffer, containing 0.5%
glucose. Afterwards the medium was aspirated and
fresh medium (0.5ml of Krebs-Ringer bicarbonate
buffer containing 0.5% glucose) containing the
peptide solution was added and the mixture was then
incubated for 2min at 37°C except where otherwise
stated. After incubation, the intestinal strip was
gently blotted on filter paper, weighed, and then
digested in a scintillation vial with 0.5ml of
2M-NaOH at 75°C for 2h. After digestion, 0.5ml
of water and lOml of the scintillation mixture were
added. The scintillation mixture contained 10%
naphthalene, 0.5% 3,5-diphenyloxazole and 3%
Cab-o-Sil in dioxan. The radioactivity was measured
in a liquid-scintillation counter (Beckman model
LS-100).
For the determination of extracellular space, the
tissue was incubated with [3H]inulin under the same
conditions as for incubation with peptide solution.
The radioactivity was determined as described above.
The extracellular fluid for 2min incubation was
found to be 5% of the wet wt. of tissue. The total
water content determined separately by drying the
tissue at 110°C for 12h was found to be 78% of the
wet wt. of tissue.
During uptake glycyl-L-leucine was completely
hydrolysed so that only the free amino acids glycine
and leucine could be detected in the tissue. The tissue
uptake of ["4C]glycyl-L-leucine and glycyl-L-["4C]-
leucine was calculated from the radioactivity present
in the tissue after correcting for the extracellular
space. The uptake was calculated from the following
equation:
Uptake (gmol/min per g oftissue) =
T[(W x Pm (EC x[PE M
W~(P*]m 100
where subscripts t and m refer to tissue and medium,
respectively; [P]F is the concentration of glycyl-L-
leucine in umol/ml in the medium; P* is the c.p.m.
due to glycyl-L-leucine in the tissue; [P*]m is the
c.p.m./ml due to glycyl-L-leucine in the medium;
W is the weight of the tissue in grams; ECV is the
extracellular volume expressed as ml ofwater present/
lOOg of tissue; Tis the time of incubation in minutes.
All values for intestinal uptake were expressed per g
wet wt. of intestine.
In separate experiments it was found that the
uptake rate with the tissue strips with both mucosal
and serosal sides exposed was not significantly
different from the rate obtained with everted seg-
ments of intestine with only the mucosal side exposed.
The everted sacs were prepared by the method of
Malathi et al. (1973).
All the incubations were carried out in duplicate
with the tissue from the same animal. In some experi-
ments (Figs. 1 and 2a) the experiments were repeated
in a second animal. The variations were not more
than ±15% between animals and often within ±5%
in the same animal.
All the incubation experiments were started
immediately after the animal was killed and the
experiments were completed within 1 h. However,
it was found by separate experiments that the tissue
maintained in oxygenated Krebs-Ringer buffer
showed no deterioration in the uptake property
almost up to 3 h after killing the animal. Longer
storage of the tissue in the oxygenated Krebs-Ringer
buffer at 0°C resulted in gradual loss of dipeptide
uptake. It is noteworthy that the dipeptide-uptake
rate decreased drastically when younger monkeys
below about 2kg weight were used.
Results
Time-course of uptake
The time-course of uptake of ["C]glycyl-L-leucine
and glycyl-L-[14C]leucine by monkey intestine is
shown in Fig. 1. The uptake is linear up to about 2min.
Within this time about 10% of the peptide in the
medium is hydrolysed. The marked difference in the
uptake rates of glycine and leucine residues of
glycyl-L-leucine is noticeable throughout the 20min
time-course. After the initial 5min glycyl-L-leucine
may be transported mainly in the form of amino
acids, since there is extensive hydrolysis of the
peptide in the medium. However, it should be
emphasized that the bulk of the uptake as measured
in the 2min period was due to uptake of intact
dipeptide, since only dipeptides but not free amino
acids effectively inhibited this uptake (Das &
Radhakrishnan, 1974b). Secondly, the existence of
extremely powerful dipeptidases leads to total
hydrolysis of the dipeptides entering the cell, even
with the very short incubation period employed.
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Fig. 1. Time-course of uptake of [14CIglycyl-L-keucine (A)
and glycyl-L-[14C]Jeucine (O) in the monkey intestine
The concentration of peptide in the medium was 0.5mM.
The specific radioactivity of ['4C]glycyl-L-leucine and
glycyl-L-[VC]leucine in the medium varied between
2 x 105 and 3 x 105c.p.m./,umol of glycyl-L-leucine. Extra-
cellular space was determined for the time-periods shown
in the Figure.
Kinetic characteristics Of ["4C]glycyl-L-leucine uptake
and glcyl-L-['4C]leucine uptake
The effect of concentration of glycyl-L-leucine in
the medium on the rate ofaccumulation ofglycine and
leucine residues is shown in Fig. 2. In the monkey
intestine (Fig. 2a), the K, values for uptake of both
glycine and leucine residues are similar, but there
is a marked difference in the Vmax. values. In the
human intestine also the situation is somewhat
similar (Fig. 2b). Both ["4C]glycyl-L-leucine uptake
and glycyl-L-['4C]leucine uptake have similar K,
values. The difference in the Vmax. values in this case
are not so marked as in the case of monkey.
If the dipeptides are transported intact into
mucosal cells, it would be expected that the two amino
acid residues of the peptide would be accumulated
inside the cell to the same extent. But in actual
experiments in the present study a marked difference
in the uptake rates of glycine and leucine residues of
glycyl-L-leucine was observed (Fig. 2a). Such
differences have also been noticed by earlier
workers (Burston et al., 1972) although an
explanation is not readily available for this anomalous
result. To understand this phenomenon, a study was
made on the rates of efflux of glycine and leucine
from monkey intestinal strips. The intestinal strips
were preloaded with ['4C]glycine or [14C]leucine
by incubating with these amino acids (0.5mM) for
5min. After washing the preloaded tissue with ice-
cold Krebs-Ringer bicarbonate buffer, these were
incubated at 37°C for 3min in the same buffer to
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Fig. 2. Lineweaver-Burk plots for [14C]glycyl-L-keucine
uptake (A) and glycyl-L-[14C]leucine uptake (0) in the
monkey (a) and in the human (b)
All incubation media were adjusted to an osmolarity of
346mosmol/litre with appropriate additions of mannitol.
The specific radioactivity of ['4C]glycyl-L-leucine and
glycyl-L-[14C]leucine in the medium varied between
1 x 10 and 3 x 105c.p.m./pmol of glycyl-L-leucine. v is
expressed as ,umol absorbed/min per g of tissue. The
kinetic constants for the monkey intestinal uptake system
are: Vma.. for [14C]glycyl-L-leucine = 0.50Oumol/min per g
of tissue; Vmax. for glycyl-L-[t4C]leucine = 1.43,pmo1/min
per g of tissue; Kt for [14C]glycyl-L-leucine = 4mM;
Kt for glycyl-L-[14C]leucine = 4mM. The kinetic constants
for the human intestinal uptake system are: Vmax. for
[I4C]glycyl-L-leucine = 1.4pmol/min per g of tissue;
Vmax. for glycyl-L-[14C]leucine = 2.2,umol/min per g of
tissue; Kt for [14C]glycine-L-leucine = 2.5 mM; Kt for
glycyl-L-['4C]leucine = 2.5 mM.
measure the efflux of radioactivity into the medium.
The endogenous amounts of glycine and leucine
in the tissue were determined by using an alcoholic
[80% (v/v) ethanol] extract of the tissue. The amino
acids were measured by using an automatic amino
acid analyser. The endogenous tissue amount of
glycine was found to be about 3 times the tissue
amount of leucine. The efflux rates of glycine and
leucine were calculated by using these data. The rate of
efflux of glycine from the tissue was found to be at
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Table 1. Specificity ofthe monkey intestinalglycyl-L-leucine uptake system
In these experiments the concentration of 'IC-labelled glycyl-L-leucine was 0.5mm and the concentration of the unlabelled
peptides was lOmIim in all cases. The specific radioactivity varied between 2 x 101 and 2 x 106c.p.m./hImol of glycyl-L-leucine.
All the peptides, excepting glycyl-D-leucine, contained amino acids of the L configuration. Different animals were used for
a given number of dipeptides and the values are expressed as a percentage of the observed glycyl-L-leucine uptake in each
experiment. Z, N-benzyloxycarbonyl; Gly-y-Abu, glycyl-y-aminobutyric acid.
% inhibition of uptake of
Peptide ["'C]Glycyl-L-leucine Glycyl-L-["'C]leucine
Gly-Gly
Gly-Ala
Gly-Val
Gly-fle
Gly-Leu
Gly-Ser
Gly-Phe
Gly-Trp
Gly-His
Gly-Met
Ala-Gly
Ala-Ala
Ala-Leu
Ala-Ser
Ala-Phe
Ala-Met
Leu-Gly
Ser-Leu
Met-Leu
Gly-Pro
Pro-Gly
24
42
70
80
82
53
51
44
45
70
82
73
89
88
80
85
74
84
70
76
63
20
50
65
78
86
70
73
67
63
86
70
73
92
74
86
86
87
85
91
69
51
Peptide
Gly-Asp
Gly-Glu
Gly-Asn
Ala-Asp
Met-Glu
Asp-Gly
Glu-Ala
Glu-Val
Glu-Glu
Gln-Gln
Tyr-Lys
Lys-Phe
Lys-Lys
Gly-D-Leu
Z-Gly-Leu
Gly-fi-Ala
Gly-y-Abu
Gly-Gly-Leu
Gly-Leu-Gly
Gly-Gly-Gly
%Y inhibition of uptake of
[14C]Glycyl-L-leucine Glycyl-L-["4C]leucine
38
49
50
52
62
43
60
79
57
70
72
70
64
12
15
15
25
60
62
26
50
42
63
62
64
40
54
58
54
76
77
67
62
10
30
20
32
58
58
20
least twice the rate of efflux of leucine. Supporting
this line of evidence was the observation that when
labelled glycyl-L-leucine was used, the specific
radioactivity of glycine in the medium was diluted
about twice, although there was no dilution of
leucine radioactivity. These results suggest that the
higher efflux rate of glycine may be partly
responsible for the lower uptake of glycine residue
compared with the uptake of leucine residue.
Structural specificity of glycyl-L-leucine uptake in
monkey intestine
The uptake ofboth ["C]glycyl-L-leucine and glycyl-
L-["'C]leucine is inhibited by a wide variety of
dipeptides, including dipeptides of the composition:
neutral-neutral, neutral-acidic, acidic-neutral,
neutral-basic, basic-neutral, basic-basic and acidic-
acidic (Table 1). As noted in our preliminary study
(Das & Radhakrishnan, 1974b), the degree of
inhibition seems to be dependent on the hydro-
phobicity of the peptide. Peptides such as glycyl-L-
isoleucine, glycyl-L-methionine, L-alanyl-L-leucine,
L-alanyl-L-serine, L-alanyl-L-phenylalanine, L-
alanyl-L-methionine, L-leucyl-glycine, L-seryl-L-
leucine, and L-methionyl-L-leucine are the strongest
inhibitors of glycyl-L-leucine uptake. The nature of
the N-terminal amino acid also appears to determine
the inhibitory capacity, since L-alanyl-glycine is a
stronger inhibitor than glycyl-L-alanine. The slight
inhibition obtained with glycyl-glycine is in contrast
with our earlier findings (Das & Radhakrishnan,
1974b) in which, by a chemical method, glycyl-L-
leucine uptake was shown to be unaffected in the pres-
ence of glycyl-glycine. However, considering the
higher sensitivity of the present procedure, the
results reported here may be more reliable.
The basic dipeptides are comparable with the
neutral dipeptides in their inhibitory capacity. The
acidic dipeptides are poor inhibitors compared with
the neutral and basic peptides. However, amidation
of the dicarboxylic amino acid residues results in a
higher inhibitory capacity, since L-glutaminyl-L-
glutamine and glycyl-L-asparagine are stronger
inhibitors than L-glutamyl-L-glutamic acid and glycyl-
L-aspartic acid respectively.
To understand the nature of inhibition, four
representative dipeptides namely, L-alanyl-L-alanine,
L-alanyl-L-leucine, L-lysyl-L-lysine and L-glutamyl-
L-glutamic acid were used to study their effects on the
kinetic constants of glycyl-L-leucine uptake. As
shown in Fig. 3, all these four dipeptides inhibit
glycyl-L-leucine uptake by increasing the K,,
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Fig. 3. Lineweaver-Burk plots for glycyl-L-[14C]leucine
uptake in the monkey intestine, in the presence and absence
of various inhibitory peptides
o, Glycyl-L-leucine alone; the other curves refer to incu-
bation of glycyl-L-leucine with 2.5mM-L-lysyl-L-lysine
(A); with 5mM-L-glutamyl-L-glutamic acid (O); with
5mM-L-alanyl-L-alanine (@); with 5mM-L-alanyl-L-leucine
(A). The specific radioactivity of glycyl-L-[14C]leucine in
the medium varied between 1 x 10 and 1 xlO6c.p.m./
,umol of glycyl-L-leucine. v is expressed as pmol/min
per g of tissue.
substitution of the peptide or-amino group provided
that this can be achieved with retention of the
positive charge. Peptides containing 8- or y-amino
acids (glycyl-,B-alanine or glycyl-y-aminobutyric
acid) are poor inhibitors of uptake.
In the present study, a few tripeptides were
also tested for inhibitory activity. All the three
tripeptides (glycyl-L-leucyl-glycine, glycyl-glycyl-L-
leucine, and glycyl-glycyl-glycine) inhibit glycyl-L-
leucine uptake. It isnotyet clearwhether this inhibition
is due to tripeptides per se or due to the dipeptides
formed by hydrolysis by the brush-border tri-
peptidases. It is noteworthy that the extent of
inhibition by these tripeptides is similar to that of
the dipeptides which results from amino-tripeptidase
action on the tripeptides.
Although the final uptake value of the two amino
acid residues of glycyl-L-leucine was different, the
degree of inhibition of the uptake of both glycine and
leucine residues in the presence of a particular
inhibitory peptide was almost identical.
Specificity ofglycyl-L-['4C]leucine uptake in the human
The specificity of glycyl-L-['4C]leucine uptake in
the human intestine was studied in a very limited way.
All the five dipeptides tested were inhibitory (Table 2).
L-Alanyl-L-leucine and L-lysyl-L-phenylalanine were
strong inhibitors, whereas L-glutamyl-L-glutamic
acid, glycyl-L-proline and L-prolyl-glycine were less
potent inhibitors. The results suggest that the
specificity of dipeptide uptake in the human may be
very similar to that in the monkey.
Effect of temperature on uptake
The effect of temperature on the uptake of
glycyl-L-leucine in monkey intestine is shown in
Fig. 4. In these experiments a higher concentration
of glycyl-L-leucine (40mM) was used to obtain near-
maximal velocities. Das & Radhakrishnan (1974b)
whereas the Vmax. is not altered. This suggests that the
dipeptides which inhibit glycyl-L-leucine uptake are
also transported by the same glycyl-L-leucine uptake
system. On the basis of this assumption the
dipeptide uptake system in monkey intestine appears
to have a very broad specificity.
The glycyl-L-leucine uptake system is highly
stereospecific since glycyl-D-leucine does not inhibit
uptake to any significant extent. The N-terminal
a-amino group appears to have an important role in
uptake, since N-benzyloxycarbonyl-glycyl-L-leucine
is a poor inhibitor of uptake. However, substitution
of the N-terminal a-amino group hydrogen does not
always affect inhibitory capacity, as L-prolyl-glycine
is a good inhibitor. Thus it appears that the dipeptide
uptake system in monkey intestine can tolerate
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Table 2. Specificity of the human intestinalglycyl-L-[14C]-
leucine uptake system
In these experiments the concentration of glycyl-L-['4C]-
leucine was 0.5mM and the concentration of the
unlabelled peptides was 10mM in all cases. The specific
radioactivity varied between 2xlOs and 2x106c.p.m./
,umol of glycyl-L-leucine. All the peptides contained
amino acids of the L configuration.
Peptide
Ala-Leu
Lys-Phe
Glu-Glu
Gly-Pro
Pro-Gly
%Y inhibition of uptake
of glycyl-L-[4C]leucine
89
69
22
44
32
137
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Fig. 4. Arrhenius plots for [14C]g(A) and glycyl-L-[14C]eucine uptai
intestine
The concentrationof glycyl-L-leuci
40mM. The specific radioactivity o
and glycyl-L-['4C]eucine in theml1 x IO' and I xIO6c.p.m./pmol of
extracellular space was determine
shown in the figure. v is expressed
per g of tissue.
showed that glycyl-L-leucine
saturated at 40mM concentratiol
Arrhenius plots for both
uptake and glycyl-L-[14C]eucii
discontinuity at about20°C. Thifor ["4C]gycyl-L-leucine uptake,
discontinuity are 24.7kJ/mol an(
tively. The corresponding value
leucine uptake are 23 kJ/mol
Since there is a sharp increas
energy of the uptake system be
appear that the fluidity of tl
components may have an imj
uptake process. These results a
same uptake mechanism may b(
uptake of both ["4C]glycyl-L-le[14C]leucine.
Discussion
To study the early event
absorption of a dipeptide ar
necessary. A direct measurement of the uptake of
each dipeptide is not possible in view of the
high cost or paucity of some of the peptides
especially with 'IC labelling. In the present study,
these difficulties were circumvented by studying
the inhibition of uptake of a single 'IC-labelled
dipeptide, namely glycyl-L-leucine, by a wide range of
judiciously selected unlabelled peptides. Although
the method is indirect it is considered that the data
0 obtained provide adequate proof for a generalA\ \ dipeptide uptake system.
The specificity of the intestinal dipeptide uptake
system has been studied earlier by Rubino etal. (1971)
and Das & Radhakrishnan (1974b). After submission
of this manuscript we have seen the papers by
A\ Matthews and his co-workers on the uptake of
\A carnosine in rings of everted hamster jejunum in vitro
(Matthews etal., 1974). Since carnosine is very slowly
hydrolysed the intact peptide was detectable in the
intestine wall. They have also found that there isI'4
-3'- competition between camosine and other dipeptides
.4 3.5 3.6- and triglycine (Addison et al., 1974). In these studies
the uptake of neutral dipeptides was shown to be
rIycyl-L-leucine uptake inhibited by other neutral dipeptides, but not by the
ke (a) in the monkey constituent amino acids. In the present paper a more
detailed study was made on the specificity of dipeptide
ine in the medium was uptake by using a wider variety of peptides,
'f ['4CJglycyl-L-leucine including those containing acidic or basic amino
edium varied between acids. The results strongly suggest that in the
glycyl-L-leucine. The monkey intestine there is a dipeptide uptake system
d at the temperatures with an extremely broad specificity. In this respect the
as umol absorbed/min dipeptide uptake system in the monkey appears to
resemble the bacterial system (Payne & Gilvarg,
1971). The neutral, basic and acidic dipeptides all
appear to share the same uptake system. In the case
of free amino acid transport, there is evidence for
uptake at 37°C is separate uptake systems for basic and neutral amino
of the peptide. The acids, and acidic amino acids do not compete with
["4C]glycyl-L-leucine neutral amino acids for transport (Wilson, 1962).
ne uptake show a Thus the nature and specificity of dipeptide
activation energies transport is entirely different from that of free amino
above and below the acid transport. There may be only one uptake system
49.8kJ/mol respec- for transporting all types of dipeptides derived from
5sfor glycyl-L-['4C] dietary proteins. A relatively non-specific uptake
I 57.4kJ/mol.
system for dipeptide can be expected when it is
considered that the number of theoretically possible
-low 20°C, it would dipeptides exceeds 400. The uptake mechanism
he membrane lipid operating for such a large group would be expected
portant role in the to have a rather broad specificity.
Iso suggest that the In earlier studies on dipeptide absorption in the
5 responsible for the human, uptake wasmeasured by the perfusion
ucine and glyCyl-L- technique (Adibi, 1971; Hellier etal., 1972a; Hellier
etal., 1972b). The method of measurement in vitro
adopted in the present work, presumably gives a more
accurate measure of the rate of initial entry of the
peptide into the mucosal cell, but it does not give an
in the intestinal idea of the overall absorption rate. The present study
sensitive method is on glycyl-L-leucine uptake in the human is somewhat
1975
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limited, but it throws some light on the kinetics of the
initial entry process which has never been studied
before. Also the inhibition of glycyl-L-leucine uptake
by dipeptides which are structurally unrelated to
glycyl-L-leucine indicates that the uptake system
in the human may also have a broad specificity.
In monkey intestine the uptake of glycine and
leucine residues of glycyl-L-leucine show great
similarities in several properties like K, value and
activation energy. Also in the Arrhenius plots, both
show discontinuities at 20°C. The similarities in the
characteristics of uptake of the two amino acid resi-
dues of a mixed dipeptide support the hypothesis
that dipeptides are transported as one unit. However,
the marked difference in the uptake rates of [14C]-
glycyl-L-leucine and glycyl-L-14[C]leucine appar-
ently contradicts this idea. This anomalous absorption
ofmixed dipeptides has also been observed by Burston
et al. (1972). In the present study the observed higher
efflux rate of glycine can partly explain this pheno-
menon. The observed lower efflux of leucine may be
due to a more efficient recapture of free leucine from
the lumen. Also it should be noted that the brush-
border dipeptidases will hydrolyse glycyl-L-leucine to
a certain extent, and the liberated amino acids may
be taken up at different rates.
Discontinuities in the Arrhenius plots of several
membrane-associated functions have been inter-
preted in terms of a phase change in the membrane
lipids (Wilson et al., 1970; Esfahani et al., 1971).
The increase in activation energy below the
discontinuity is ascribed to close packing of the
hydrocarbon chains of membrane lipids. The
discontinuities observed in the Arrhenius plots for
[I4C]glycyl-L-leucine uptake and glycyl-L-[14C]-leu-
cine uptake strongly suggest that the physical state
of the membrane lipid components is an important
factor in determining peptide uptake.
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